Articles Longterm incidence of severe malaria following RTSSAS01 vaccination in children and infants in Africa an openlabel 3year extension study of a phase 3 randomised controlled trial

[Articles] Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

20:37 EDT 9 Jul 2019 | The Lancet

Overall, severe malaria incidence was low in all groups, with no evidence of rebound in RTS,S/AS01 recipients, despite an increased incidence of clinical malaria in older children who received RTS,S/AS01 compared with the comparator group in Nanoro. No safety signal was identified.

More From BioPortfolio on "[Articles] Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial"